J Cancer 2019; 10(2):416-417. doi:10.7150/jca.29461

Letter To The Editor

Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer

Guoxing Wan, Fengjun Cao, Xuanbin Wang, Xue Sun

Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, China.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Wan G, Cao F, Wang X, Sun X. Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer. J Cancer 2019; 10(2):416-417. doi:10.7150/jca.29461. Available from http://www.jcancer.org/v10p0416.htm